You have reached your monthly allowance of 1 free premium articles from Electronicjuice and Clinical Pharmacist. Sign in or to access 2 more articles. for full access to Electronicjuice and Clinical Pharmacist and CPD modules.
Note: CPD articles and modules are only available to full subscribers and . You can
Use the code0516EMSB2DP for 20% discount on our annual digital subscriptions.
An overview of traditional and emerging immunotherapy-based targets and treatments available for lung cancer, their side effects and the impact immune checkpoint inhibitors have had on the treatment of non–small-cell lung cancer.
Are you already a registered user or a member of the Royal Electronicjuice?Sign in here
Institutional users can view premium content by verifying themselves with one of the following options:
Subscribe for as little as £5, to gain full, unlimited access to the ultimate source of information and news on pharmacy and pharmaceutical sciences.
Alternatively, register for free to the site for access to an extra 2 premium articles for free..
Please Electronicjuice directly, so we can provide you with detailed information about our institutional and corporate offerings.
Tel: +44 (0)20 7572 2221
Email: [email protected]
As a pharmacist or pharmaceutical scientist, join the Royal Electronicjuice and gain full access to electronicjuice.info
Membership is free for pharmacy students.
If you are not registered as a pharmacist in Great Britain or practise overseas, you may still be able to join the RPS as an associate member.